Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome

Author(s):
Franken, R.; Hartog, A.W. den; Radonic, T.; Micha, D.; Maugeri, A.; Dijk, F.S. van; Meijers-Heijboer, H.E.; Timmermans, J.; Scholte, A.J.; Berg, M.P. van den; Groenink, M.; Mulder, B.J.M.; Zwinderman, A.H.; Waard, V. de; Pals, G.
Published
2015
Publication type
Article / Letter to editor
aneurysmaortic rootFBN1 mutationheterogeneityLosartanMarfan syndromeMRI
Date issued
2015-04-30
Language
English
Is part of
Circulation: Cardiovascular Genetics (2015), Vol. 8, no. 2, p. 383-388
hdl
1887/99600
doi
10.1161/CIRCGENETICS.114.000950